News for Catalyst Biosciences, Inc. (CBIO)

News for Catalyst Biosciences, Inc.
Date Headline
Apr 23, 2018 08:00 AM Catalyst Biosciences Announces Presentation at the 2018 Association for Research in Vision and Ophthalmology Annual Meeting
Apr 12, 2018 08:00 AM Catalyst Biosciences Announces Korean Ministry of Food and Drug Safety Approves Addition of Sixth Cohort to the Phase 1/2 Trial of CB 2679d/ISU304 in Individuals with Hemophilia B
Mar 30, 2018 08:30 AM Analysis: Positioning to Benefit within Catalyst Biosciences, CorEnergy Infrastructure Trust, PennyMac Mortgage Investment Trust, Raven Industries, Acacia Communications, and Sandy Spring — Research Highlights Growth, Revenue, and Consolidated Results
Mar 26, 2018 08:00 AM Catalyst Biosciences Receives $1.5 Million In Two Milestone Payments for Neuronal Nicotinic Receptor (NNR) Asset
Mar 19, 2018 08:00 AM Catalyst Biosciences to Present at The Needham and Company 17th Annual Healthcare Conference
Mar 09, 2018 07:40 AM Zacks.com featured highlights include: Unisys, Catalyst, Liberty and New Mountain
Mar 07, 2018 08:00 AM Catalyst Biosciences to Present at The Cowen and Company 38th Annual Health Care Conference
Mar 05, 2018 04:01 PM Catalyst Biosciences Announces the Calling of Remaining Warrants and Conversion of Remaining Series A Preferred Shares Issued April 12, 2017
Mar 01, 2018 08:30 AM Catalyst Biosciences Reports Fourth Quarter and Full-Year 2017 Operating & Financial Results and Provides Corporate Update
Feb 26, 2018 08:00 AM Catalyst Biosciences Announces Manufacturing Agreement with AGC Biologics for Subcutaneous Factor IX Product CB 2679d